• Home
  • Cooley team
  • Resources
  • Cooley.com
Explore Close
Menu Close

Categories

ExperienceInsightRegulatoryMarket UpdatesDeal TermsEventsDeal LitigationFiduciary DutiesCrossborderSPACsExitsFirm NewsDue DiligenceLitigationSPACs

Tags

AntitrustDelawareTrendsJudicialPrivate EquityDeal TermsLitigationRegulatoryCrossborderLife SciencesActivismTechEarnoutsFiduciary DutiesSECAppraisalCOVID-19United KingdomCFIUSSPACs

Archives

September 2026 August 2026 July 2026 June 2026 May 2026 April 2026
  • Home
  • Cooley team
  • Resources
  • Cooley.com
  • Insight
  • Events

Cooley M&A

Key deals, decisions + trends

  • Insight
  • Events
Close

Brandwatch Agrees to Sell to Cision for $450 Million

Brandon C / March 17, 2021

Archer to Combine With SPAC Atlas Crest Investment

Brandon C / March 10, 2021

Thoma Bravo’s Instructure Agrees to Sell Employee Development Platform Bridge to Learning Technologies Group

Brandon C / March 3, 2021

Origin to List on Nasdaq via SPAC Merger With Artius

Brandon C / March 2, 2021

Humio Agrees to Sell to CrowdStrike for $400 Million

Brandon C / February 25, 2021

Datadog to Acquire Sqreen, Extending Cloud Security Capabilities

Brandon C / February 19, 2021

Horizon Therapeutics to Acquire Viela Bio to Grow Rare Disease Medicine Portfolio

Brandon C / February 18, 2021

AvePoint to Combine With Apex Technology, a Special Purpose Acquisition Company, at $2 Billion Value

Brandon C / February 16, 2021

InvestCloud Recapitalizes at $1 Billion and Integrates Two New Businesses

Brandon C / February 12, 2021

Uber to Acquire Drizly for $1.1 Billion

Brandon C / February 7, 2021
← 1 … 21 22 23 24 25 … 40 →

Cooley has handled 1,600+ M&A transactions for an aggregate value of $750+ billion since 2021, making our practice one of the most active in the world. Learn more

Loading

By signing up for Cooley blog/marketing messages, we will only process your personal information for the purpose of sending you marketing emails in accordance with our Privacy Policy. We do not sell your information or share it with any third-parties other than those necessary for this purpose. You can unsubscribe by clicking the unsubscribe link in any email we send you. You may have other rights with respect to your information which are detailed in our PrivacyPolicy, / Cookies Policy.

Recent M&A transactions

  • GPTZero to be Acquired by Superhuman
  • First Street Acquired by MSCI
  • CRED Receives Significant Investment From Meta
  • Fin to be Acquired by Salesforce for Approximately $3.6 Billion
  • Cooley Advises ZincFive on DeSPAC Transaction With Spark I Acquisition Corp
  • Avenzo Therapeutics to be Acquired by Rallybio
  • Curevo Vaccine to be Acquired by Eli Lilly for up to $1.5 Billion
  • Vaccine Company to be Acquired by Eli Lilly for up to $1.5 Billion
  • Engage Bio Acquired by Eli Lilly for up to $202 Million
  • Orphai Therapeutics Sale to Quince Therapeutics

View more transactions

Recent posts

  • Spooky Season: Merger Agreements Rise From the Dead in Verisk Ruling
  • DOJ Announces ‘Historic’ $250 Million Penalty for HSR Filing Violations
  • Choosing Your Corporate Home: A Trade-Off Guide for Founder-Led Tech Companies
  • FTC, Requiring Divestitures, Approves Final Consent Decree in Ascension/AmSurg Deal
  • FTC Court Win Blocks Henkel’s Acquisition of Liquid Nails

Disclaimer

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may hve been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.

Cooley M&A

Cooley has handled 1,600+ M&A transactions for an aggregate value of $750+ billion since 2021, making our practice one of the most active in the world. Learn more ›

Recent

  • Spooky Season: Merger Agreements Rise From the Dead in Verisk Ruling
  • DOJ Announces ‘Historic’ $250 Million Penalty for HSR Filing Violations
  • Choosing Your Corporate Home: A Trade-Off Guide for Founder-Led Tech Companies
  • FTC, Requiring Divestitures, Approves Final Consent Decree in Ascension/AmSurg Deal
  • FTC Court Win Blocks Henkel’s Acquisition of Liquid Nails

Categories

  • Crossborder
  • Deal Litigation
  • Deal Terms
  • Due Diligence
  • Events
  • Exits
  • Experience
  • Fiduciary Duties
  • Firm News
  • Insight
  • Litigation
  • Market Updates
  • Regulatory
  • SPACs
  • SPACs